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ABSTRACT
Conventional cancer therapies are often limited in
effectiveness and exhibit strong side effects.
Therefore, alternative therapeutic strategies are
demanded. The employment of tumor-colonizing
bacteria that exert anticancer effects is such a
novel approach that attracts increasing attention.
For instance, Salmonella enterica serovar
Typhimurium has been used in many animal tumor
models as well as in first clinical studies. These
bacteria exhibit inherent tumoricidal effects.
In addition, they can be used to deliver therapeutic
agents. However, bacterial expression has to be
restricted to the tumor to prevent toxic substances
from harming healthy tissue. Therefore, we
screened an S. Typhimurium promoter-trap library
to identify promoters that exclusively drive gene
expression in the cancerous tissue. Twelve
elements could be detected that show reporter
gene expression in tumors but not in spleen and
liver. In addition, a DNA motif was identified that
appears to be necessary for tumor specificity.
Now, such tumor-specific promoters can be
used to safely express therapeutic proteins by
tumor-colonizing S. Typhimurium directly in the
neoplasia.
INTRODUCTION
Bacteria can cause devastating, sometimes fatal diseases.
It is often overlooked that only a minority of bacteria is
responsible for these severe illnesses. Most of them are not
harmful and some are even beneficial for human health.
For instance, the gut microflora counteracts the invasion
of pathogenic microorganisms (1). Consequently,
particular bacteria like the Escherichia coli Nissle 1917
strain are employed for medical treatment (2). An add-
itional promising application of bacteria or bacterial prod-
ucts is the therapeutic treatment of cancer. Astonishingly,
already >150 years ago first attempts to use bacteria for
such therapeutic approaches have been made. They were
based on the observation of several clinicians who
correlated bacterial infection of cancer patients with
regression of the tumor (3). The major drawback of the
therapy at that time was the uncontrollable toxicity of the
bacteria. Therefore, this treatment strategy was disre-
garded for many decades.
Today, as various possibilities exist to tailor bacteria for
a particular purpose, bacteria-mediated tumor therapy
undergoes a spectacular renaissance (4). For several
bacterial strains, including not only obligate anaerobic
bacteria like Clostridia or Bifidobacteria but also faculta-
tive anaerobic bacteria like E. coli or Salmonella, it could
be shown that they preferentially colonize tumor tissue
when administered systemically. This colonization can
lead to the shrinkage or even the clearance of the neopla-
sia (5). Possible explanations for this growth preference
can be found in the physiological composition of solid
tumors. Most of such tumors contain central areas of
low oxygen and scarce external nutrient supply resulting
in the formation of necrotic regions. These areas provide
optimal growth conditions for the bacteria as they repre-
sent niches with high amounts of nutrients from the dead
cells and protection from the immune system.
Salmonella enterica serovar Typhimurium is among the
bacteria that preferentially target and colonize tumors
upon systemic administration (6). As consequence, the
tumor usually shrinks but often regrows after a lag
period. Different possibilities to improve Salmonella’s
inherent anticancer effects are under intensive investiga-
tion. For instance, dedicated mutant strains were estab-
lished like A1-R, which was rendered auxotrophic for
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leucine and arginine and resisolated from tumors. It pref-
erentially colonizes various human tumors and metastates
in nude mice but is cleared rapidly from other organs
(7–10). In addition, the therapeutic power of the bacteria
is strengthened by enabling the bacteria to express recom-
binant therapeutic molecules (5). However, such bacteria
would also colonize spleen and liver, the normal target
organs of S. Typhimurium. Thus, to fully exploit an
enhanced antitumor potential such bacteria need to be
manipulated to express the therapeutic molecules exclu-
sively in the tumor tissue and not in healthy organs.
This restricted expression represents an absolutely neces-
sary safety aspect.
In the present work, this aspect was tackled
by searching for tumor-specific Salmonella regulatory
sequences. A promoter-trap library was used to systemat-
ically screen the Salmonella genome for sequences that
activate the expression of their corresponding gene only
when the bacteria reside within a tumor and not in other
organs. Here, we indentified 12 genomic fragments
that exhibited the desired expression pattern in vivo.
Fragmentation of four of such sequences, as examples,
leads to a further confinement of the genomic sequence
that is necessary for tumor specificity. In addition, a
DNA sequence motif was identified that dominantly con-
tributes to the specific pattern of expression.
MATERIALS AND METHODS
Ethics statement
Procedures involving animals and their care were fully
in compliance with the German Animal Welfare Act
(Tierschutzgesetz, 1998) and with the permission number
33.9.42502-04-050/09 of LAVES (Niedersaechsisches Land-
esamt fu¨r Verbraucherschutz und Lebensmittelsicherheit).
Bacterial strains and growth conditions
Salmonella Typhimurium strain SL7207 (hisG, aroA)
was kindly provided by Bruce Stocker (11) and was
grown with vigorous shaking in LB medium containing
30 mg/ml streptomycin (Sigma-Aldrich, Germany) and
50 mg/ml ampicillin (Sigma-Aldrich, Germany) when
needed for plasmid selection at 37C or on respective LB
agar plates. If needed, hypoxic conditions were established
by sparging an aerobic liquid culture in early log phase
with nitrogen before further incubation at 37C under air
exclusion.
Cell lines and animals
Six-week-old female BALB/c mice were purchased from
Harlan (Germany). CT26 colon carcinoma cells (ATCC
CRL-2638) were grown as monolayers in IMDM medium
(Gibco BRL, Germany) supplemented with 10% (v/v)
heat-inactivated fetal calf serum (Integro, Netherlands),
250 mmol/l b-mercaptoethanol (Serva, Germany) and 1%
(v/v) penicillin/streptomycin (Sigma-Aldrich, Germany).
Promoter-trap library construction
Briefly, S. enterica serovar Typhimurium SL1344 genomic
DNA had been sheared and fragments of 500–700 bp had
been inserted upstream of a promoter less gfp_ova gene on
a medium copy number plasmid. The resulting plasmid
library contains about 1.1 106 independent transcrip-
tional fusions (12). This DNA was used to transform
S. Typhimurium SL7207 resulting in about 1 106 inde-
pendent transformants.
Mouse experiments
Female BALB/c mice aged 6–8-weeks were subcuta-
neously (s.c.) inoculated at the abdomen with 5 105
CT26 cells. When tumors reached volumes of approxi-
mately 200mm3, infection experiments were started. For
the first sorting, an aliquot of the promoter-trap library
was thawed on ice for 30min. Subsequently, it was
included in prewarmed Lysogeny broth (LB) medium
and incubated for 30min at 37C. After washing with
PBS three times, the inoculum was adjusted to obtain an
infectious dose of 1 107 either in 10 ml for intratumoral
(i.t.) infections or in 100 ml for intravenous (i.v.) infections.
For infection with single strains, the respective strain was
grown overnight on agar plates, resuspended in
phosphate-buffered saline (PBS) and adjusted to an infec-
tious dose of 5 106.
Sorting and flow cytometric analysis
Twenty-four hours after infection, respective organs and/
or tumors were removed and homogenized in 2ml ice-cold
PBS. Then, the homogenates were diluted to 1 : 10 (spleen,
liver) or 1 : 100 (tumors) in 0.1% Triton-X/PBS containing
2mM EDTA, filtered through a 30 -mm CellTrics filter
(Partec, Germany) and sorted or analyzed via two-color
flow cytometry on a FACSAria or LSRII (Becton
Dickinson, USA). Two-color flow cytometry is a method
that allows distinguishing GFP-expressing bacteria from
autofluorescent cellular debris since GFP-expressing
Salmonella have a substantially lower orange/green
emission ratio (13). Additionally, forward and side
scatter were used to distinguish Salmonella from larger
particles by setting an appropriate scatter gate.
Sequencing and analysis of sequence data
Plasmid DNA of sorted bacteria forming colonies on LB
agar plates were prepared and inserts were sequenced on
Genome Analyzer (Illumina Inc., USA) using primer
SLE06 (50 GTGATGTCGGCGATATAG 30) and SLE07
(50 GAATTGGGACAACTCCAG 30) (12). Sequences
were aligned using BLAST with Salmonella chromosome
and plasmid sequence (NCBI database accession number
AE006468 and AE006471). Annotation of fragments was
done using self-developed Perl scripts and data provided
on NCBI database.
For identification of regulatory motifs, program
MEME and FIMO (14) was used with all default param-
eters. Graphical representation of the motifs was built
using WebLogo (15).
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RNA preparation
RNA of strain SL7207 was isolated from fixed samples
with the RNeasy mini Kit (Qiagen, Germany) according
to the manufacturer’s instructions using double amounts
of buffers when appropriate. For preparation of bacterial
RNA from infected tumor tissue, the tumors were cut into
small pieces and the necrotic tissue was squeezed through
a cell strainer, 70 mm (BD Falcon, USA) in presence of
3ml RNA protect bacteria reagent (Ambion, USA). For
RNA isolation of bacterial RNA from infected spleen
tissue, the organs were homogenized with a tissue hom-
ogenizer in presence of 2ml RNA protect bacteria reagent
on ice. The samples were centrifuged briefly at 1000 rpm to
separate the bacteria from tissue debris following a centri-
fugation step at maximum speed for 5min to pellet
the bacteria. RNA quality was accessed using the
Bioanalyzer (Agilent, USA).
qRT–PCR analysis
To validate the data of the promoter-trap library, qRT–
PCR was performed. Complementary DNA (cDNA) was
prepared from RNA using the RevertAid First Strand
cDNA synthesis Kit (Fermentas, Canada) according to
the instructions of the manufacturer. qRT–PCRs were
carried out with the Power Sybr Green PCR Master
Mix (Applied Biosystems, USA) and a 7500 Real-Time
PCR System (Applied Biosystems, USA). The data were
analyzed by the Sequence Detection Software, version 1.4
(Applied Biosystems, USA), according to manufacturer’s
specifications. cDNA levels were normalized to the cDNA
levels of the housekeeping gene gyrB. Normalized values
were used to calculate the ratios of the expression levels in
the colonized tumor tissue relative to the expression
during colonization of the spleen.
Construction of different insert fragments
To construct plasmids that contain fragments of the
original library inserts, oligonucleotides of the desired
sequence were ordered (Eurofins MWG Operon,
Germany) containing a BamHI recognition site at the 50
and an XbaI site at the 30-end (Table 1). For longer se-
quences, primers were designed accordingly to amplify the
fragment from the original plasmid (Table 1). As vector
the original plasmid pMW82 was used (12), opened via
restriction digestion with BamHI and XbaI followed by
a ligation with the respective fragments. SL7207 was
transformed with the plasmids and in parallel plasmid
DNA was sequenced to confirm correct amplification
products.
RESULTS
Screening the Salmonella genome for tumor-specific
regulatory elements
To define tumor-specific regulatory elements in
S. Typhimurium a promoter-trap library was employed
that has been described before (12). It consists of
random, 500–700-bp long fragments of sheared genomic
DNA from the S. Typhimurium strain SL1344 that were
cloned upstream of a gfp_ovalbumin (ova) fusion reporter
gene. The fusion of GFP with OVA renders the reporter
protein unstable. Thus, the selection of clones carrying
Table 1. Oligonucleotides used in this study
Fragment/gene Sequence of sense primer Sequence of the reverse primer
Construction of library insert fragments
48a GGATCCattgtttttcctcacagttcgtttt TCTAGAattgtagcctccgtggcccat
48b GGATCCtatgttgagtatttttaaaccagcg TCTAGAtcccgccgccgacgttatgc
48c GGATCCattgtttttcctcacagttcgtttt TCTAGAtcccgccgccgacgttatgc
134a CGGGATCCcgttattcttaaaaatgagcgtaa CGTCTAGAtcataacggcgaagttagcg
134b CGGGATCCccggcgaagcgg CGTCTAGAaataacgggtaatgtcatttgttt
134c GATCtaacttcgccgttatgatcggtcgtcttttaagcaac
tattgacacacac
CTAGgtgtgtgtcaatagttgcttaaaagacgaccgatca
taacggcgaagtta
134d GATCggttaaggtcaaagaaagacacgttctgataattctt
acttgtcattcgctaacttcgccgttatgatcggtcgtc
ttttaagcaactattgacacacac
CTAGgtgtgtgtcaatagttgcttaaaagacgaccgatcat
aacggcgaagttagcgaatgacaagtaagaattatcaga
acgtgtctttctttgaccttaacc
134e CGGGATCCcgttattcttaaaaatgagcgtaa CGTCTAGAgtgtgtgtcaatagttgcttaaaagacgaccg
atcataacggcgaagttagcg
212a GATCctttcattcgaaagtaatttaatctttatatga
aataagagaggccgttt
CTAGaaacggcctctcttatttcatataaagattaaattac
tttcgaatgaaag
212b GATCtaacgcctctttgtcagaacctctccattcgttgac
gcacatcaagatagctttcattcgaaagtaatt
taatctttatatgaaataagagaggccgttt
CTAGaaacggcctctcttatttcatataaagattaaattac
tttcgaatgaaagctatcttgatgtgcgtcaacgaat
ggagaggttctgacaaagaggcgtta
301a GGATCCggcccatattttatttagaggtaaac TCTAGAattgtttttcctcacagttcgttttt
301b GGATCCtgaaaactcgcgactcgcaaac TCTAGAatccgttttaaaatctggttttcac
301c GGATCCggcccatattttatttagaggtaaac TCTAGAatccgttttaaaatctggttttcac
qRT-PCR
mltD TGCCAGACGTCTCAGAACAC CATCGTGCCTGACTCGTAAA
PflE ATTTTCTGCCCTACCACACG GCGTACTTCTGGGCAAAATC
glpA CTGGTACCTGGCGATACGAT ACGCAGCAGGATATCGACTT
glpT CAACGAAAAAGCGGAAGAAG GCGCAGCAGATAAACAAACA
Listed are oligonucleotides for the construction of library insert fragments and for qRT-PCR.
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weakly active fusions that only accumulate GFP over time
and clones with residual reporter activity that might have
been induced in bacterial cultures or in locations other
than the tumor can be prevented. The attenuated strain
SL7207 was transformed with these library plasmids and
used for selection of tumor-specific regulatory elements.
Figure 1B displays the experimental schedule.
First, 1 107 transformants were injected directly
into the subcutaneous CT26 tumor of BALB/c mice
(Figure 1A). This appeared to be necessary to preserve
the library diversity. We had observed that the number
of tumor-invading bacteria after systemic application is
limited [(16) and Leschner, S. et al., manuscript in prep-
aration]. Tumors were homogenized 24 h post-infection
(p.i.) and green fluorescent bacteria were isolated by cell
sorting using the two-color flow cytometry to distinguish
autofluorescent cell debris from GFP signal (13). For
gating, a broad region was employed to ensure that
most positive bacteria were within the gate to enrich the
library (Figure 1C). At this step, 1.7 105 positive events
were sorted resulting in 1.2 104 colonies upon plating.
Bacteria were scraped off these plates and an aliquot of
this sample was used to inject into CT26 tumors for a
second enrichment cycle. Again, 24 h p.i. tumor homogen-
ates were sorted with a more restricted setting to enrich
transformants that strongly express the reporter gfp_ova.
From the 8 103 positive-sorted events, 3.2 103 colonies
were obtained.
To counterselect against transformants, with high ex-
pression elsewhere in the murine host, bacteria plated
after the second sorting were used as an inoculum to intra-
venously infect mice not bearing a tumor. Spleens
were homogenized 24 h p.i. and sorted for GFP negative
events. From 1 107 sorted events, 3 104 colonies were
obtained. The low fraction of viable Salmonella was due to
the fact that in this sorting strategy, GFP-negative
bacteria could not be separated from an overwhelming
number of debris of the same size.
The colonies were scraped of the plates again and an
aliquot was used to infect CT26 tumor bearing mice i.v.
Again, 24 h p.i. tumor homogenates were sorted with
restriction of the sorting to GFP-high expressing
Figure 1. Screening of a SL7207 promoter-trap library to identify tumor-specific clones. (A) Schematic depiction of the promoter-trap library. 500 to
700 bp fragments of sheared S. Typhimurium genomic DNA were inserted into a plasmid upstream of a promoterless gfp_ova reporter gene. SL7207
were transformed with these plasmids resulting in a promoter-trap library with >20-fold genome coverage. (B) Strategy to isolate tumor-specific
regulatory elements. First, two steps of positive selection of reporter gene-expressing bacteria were carried out after intratumoral application of the
bacteria (steps 1 and 2). The recovered bacteria where then negatively selected by infection of tumor-free mice and isolation of reporter negative
bacteria (step 3). This should exclude elements that generally drive expression in vivo. Finally, bacteria exhibiting high expression of the reporter were
enriched from tumors 24 h after i.v. application of the recovered bacteria (step 4). (C) Analyses of the different sorting steps. In the first step events in
the red gate (GFP pos) were sorted and in the second step the green region (GFP high) was sorted. For the negative step the blue (no GFP) and the
fourth step again the green region was taken as sorting gate.
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bacteria (Figure 1C). From the 1 104 sorted events,
3 103 colonies were formed. This strategy resulted in
an efficient enrichment of GFP-positive and especially
high GFP events in each step (Figure 1C).
Sequence analysis and classification of regulatory elements
Inserts of the library plasmids from all 3000 bacterial
colonies that were obtained during the last sorting
step were sequenced. This defined 314 unique fragments.
The sequences of these fragments were aligned with the
published genome sequence of S. Typhimurium LT2 using
BLAST. Most of the fragments showed >95% sequence
homology to the Salmonella chromosome. From the
residual fragments, 24 were fused genomic fragments of
which only the 30 part was considered for further analysis.
Five fragments matched the sequence of the Salmonella
plasmid (pSLT) and 27 showed no match. The length of
the fragments ranged from 64 to 1400 bp with an average
of 583 bp.
Annotation of the Salmonella genome was used to
localize fragments within the genomic sequence and to
identify genes for which a fragment may function as a
promoter. According to the location of the fragments
and in relation to associated genes, four different sets
were defined (Figure 2A). A fragment was assigned to
set 1 when its 30-end resided within a gene sequence and
the 50-end was upstream of that gene. A total of 117 frag-
ments fell into this category termed ‘perfect promoters’.
Set 2 fragments were specified as containing the whole
gene sequence and 24 fragments of that kind were
identified (gene inside). In both the above cases, the gene
closest to the 30-end of the fragment was considered
when a fragment overlapped with more than one gene.
Set 3 contains fragments that were found to lie completely
inside of a gene sequence. Thirty-eight of such fragments
Figure 2. Classification of the obtained promoter sequences. (A) Definition of four different sets, according to the position of the respective sequence
on the genome. (B) Classification of promoter sequences by expression pattern. After individual flow cytometric analysis, 180 insert sequences that
matched the Salmonella genome in coding sequences or in close vicinity of it, were classified according to their expression level in tumor and spleen.
Pictures show exemplary data of flow cytometric analysis, gated are GFP_OVA positive bacteria. (C) Exemplary depiction of results from
tumor-specific clones in tumor versus spleen and liver tissue. Shown is the example of clone 212.
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were found and termed ‘inside gene’. Fragments with se-
quences that showed no obvious association with a gene
fell into set 4: ‘no gene’ (107 fragments).
Using the enzyme commission (EC) nomenclature, these
sets were further analyzed for overrepresented genes
whose products might belong to the same enzymatic
class. Two groups of enzymes could be identified:
oxidoreductases (13 genes or 32.5%, expected 22.2%)
and transferases (17 genes or 42.5%, expected 31.7%).
This categorization should allow a reasonable order to
verify promising tumor-specific regulatory sequences.
This confirmation step was necessary as first random veri-
fications showed that a relatively high number of sorted
transformants did not show any expression in spleen
and in tumor. Taking the overrepresentation as a sign
of importance, transformants falling into these enzymat-
ic classes and in addition belonging to set 1 (perfect pro-
moter) were tested first for their expression. Subsequently,
the residual clones from set 1 were queued for testing, then
all clones from set 2, then from set 3 and finally from set 4.
Validation of individual regulatory sequences
Transformants representing individual regulatory se-
quences were intravenously injected into tumor-bearing
mice and the expression of the GFP reporter was
determined from homogenates of tumor and spleen.
Depending on expression levels (high, medium, low and
negative), each clone was classified into one of six classes
(Figure 2B). Reporter expression of all Class I clones
(tumorhi, spleenneg) were reanalyzed to confirm tumor spe-
cificity, including liver homogenates in addition. Strong
reporter gene expression could again be found in tumor.
No GFP signal could be detected for any of the clones in
spleen and liver (Figure 2C).
Along with experimental validation of single clones, a
positive discovery rate was monitored that appeared to
degrade drastically when analyzing sets other than set 1
(Table 2). If estimated to be linear, using data for the
entire set 1 and for sets 2 and 3 together, the expected
number of tumor-specific clones to be found in set 4
would be about 1. On this basis, further experiments
with clones that cannot be associated with a gene (set 4:
‘no gene’) were thought to be unreasonable and were not
followed any further. Interestingly, after testing the two
overrepresented EC classes (30 clones) 50% of all hits
were discovered among those fragments.
Confirmation of exemplary clone sequences
We made the assumption that each regulatory sequence
we found can be assigned to the gene that is found down-
stream of it or that it comprises. This is represented in
Table 3. To confirm that this assumption was correct,
we carried out quantitative RT-PCR for four exemplary
clones 48 (glpT), 134 (mltD), 212 (pflE) and 301 (glpA).
Apart from gene mltD that did not show to be specifically
upregulated in tumor tissue, tumor-specific expression
could be confirmed for all the other genes (Figure 3).
A complete correlation of the expression pattern given
by the library plasmid in flow cytometric analyses and
the result of the quantitative RT-PCR of the respective
gene was not expected. This can be explained not only
by the differences comparing the situation on the
genome compared to the plasmid-like topology/context
of the sequence but also by differential mRNA stabilities.
Table 3. Clones of Class I with their respective gene and its function
Clone no. Gene Function Fold induction by hypoxia
4 ydiH Putative cytoplasmic protein 59.7
48 glpT sn-glycerol-3-phosphate transporter 27.4
92 bcsG Membrane protein; endoglucanase 0.3
134 mltD Membrane-bound lytic murein transglycosylase D 1.1
154 mdh Malate dehydrogenase 1.9
156 mtfA Mlc titration factor A 15.4
172 frdA Fumarate reductase flavoprotein subunit 1368.1
185 pfkA Similar to E.coli 6-phosphofructokinase I 14.6
212 pflE Putative pyruvate formate lyase activating enzyme 150.1
271 nirB Nitrite reducatase large subunit 65.3
301 glpA sn-glycerol-3-phosphate dehydrogenase subunit A 886.6
310 ybaL Putative cation::proton antiport protein 0.4
Clones that belong to Class I (Figure 2B) show high or medium expression levels in tumor and no expression in
spleen and are, therefore, introduced in this list with their corresponding gene and its function if known. Bacterial
cultures of each clone were grown in vitro under aerobic and hypoxic conditions. Expression patterns were
compared, dividing hypoxic by aerobic values resulting in fold induction during hypoxia. Exemplary flow
cytometric results are shown in Supplementary Figure S1.
Table 2. Number of clones and positive discovery rate in data sets
according to Figure 2A
Data set Number
of clones
tested
Number
of Class I
specific clones
identified
Discovery
rate per 10
experiments
Overrepresented classes
from set 1
30 6 2.00
Residual clones from
set 1
87 4 0.46
Set 2 and set 3 62 2 0.32
Set 4 107 1a 0.12a
aExpected values.
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Induction of reporter gene expression under hypoxic
growth conditions
Due to their irregular vasculature, regions of low-oxygen
partial pressure are a characteristic of many solid tumors.
Therefore, promoters responding to a hypoxic environ-
ment should be found among the tumor-specific elements
that we had defined. To test this possibility, liquid cultures
of all Class I clones were grown under aerobic and
hypoxic conditions and subsequently analyzed for their
reporter gene expression by flow cytometry. Of the
12 clones, 8 showed strong differential GFP expression
under oxygen-deprived conditions (Table 3). Down-
regulation by hypoxia could be observed in two clones
whereas two showed equal expression under both condi-
tions. Together, an unexpected complexity of microenvir-
onments encountered by the bacteria in the tumor can be
deduced from such findings.
Discovery of regulatory motifs
Proper gene expression is usually realized by specific
binding of transcription factors (TFs) to their motifs on
the DNA. To find such motifs, which in our case should
be responsible for tumor-specific expression, the program
MEME was applied for sequences of Class I clones. This
resulted in three motifs. We expected, that true motif(s)
should be specific only to Class I sequences, but not, for
instance, to inserts of Class V exhibiting no expression.
Using Class V sequences as a negative control, only one
motif was identified, which showed the postulated specifi-
city (Figure 4A). Each sequence (except clone 156) of
Class I clones contains at least one copy of this motif
(two have two copies), while only 6% (7 out of 113) of
Class V sequences contain it. For convenience the motif
(Figure 4A) will from now on be called tusp (tumor-
specific) motif. Analysis of positional distribution of the
tusp motif in Class I fragments did not revealed any local-
ization preferences. The other two motifs either cover
<80% (10 out of 12) of Class I sequences or more than
33% of Class V sequences.
Narrowing down the tumor-specific bacterial regulatory
element
After the identification of 12 DNA fragments that drive
tumor-specific expression, the aim was to define the
shortest promoter possible, without losing functionality.
This should help to identify key elements responsible for
specificity. Since the Salmonella promoter-trap library was
built from randomly generated genomic fragments, the
potential for refinement appeared to be substantial.
Therefore, four clones from Class I with strongest expres-
sion in tumors were selected. Depending on the location of
the respective upstream and downstream genes, the four
inserts were split into several fragments, such that the
hypothesized promoter with the motif remained covered
at least by one of the fragments and the discriminative
potential was maximal (Figure 4B).
Tumor-bearing mice were i.v. infected with SL7207
transformed with each of the newly constructed plasmids,
followed by a flow cytometric analysis of tumor and
spleen homogenates after 24 h. To allow a quantitative
statement about the percentage of bacteria that are
GFP_OVA positive in the respective tissue, a defined
volume of the homogenate was analyzed and plated in
parallel. For the clones number 48 (glpT) and 301
(glpA), fragment ‘a’ representing the sequence directly
upstream of the translation start (TLS) of the associated
gene showed an expression pattern comparable to the
complete original insert (Figure 4B). The sequences down-
stream of the TLS (fragments ‘b’) did not drive any
expression. Fragments ‘c’ containing both sequences ‘a’
and ‘b’ again, were comparable in expression to the
original insert sequence. For clone 134 and 212, where
only the first 50 and 100 bp upstream of the TLS were
tested, both 50 bp fragments did not show any expression,
although the fragment from 212 contained the tusp
motif. In additional experiments using 50 bp fragments
we observed that none of them showed any expression
(S. Leschner, unpublished data). In contrast, the 100 bp
fragment 212 b showed an expression level comparable to
the original insert.
For clone 134 (mltD) not only fragments of the original
sequence were constructed but also the sequence was pro-
longed for 32 bp that included the region up to the TLS of
the mltD gene (fragments c–e). Apart from the silent
fragment c—which being 50 bp is obviously too short for
expression—both prolonged fragments showed a stronger
(S. Leschner, unpublished data) but less-specific
expression.
Analysis of clones 48, 134, 212 and 301 and their frag-
ments, provided evidence that the tusp motif identified
above may contribute to gene expression in tumors
(Figure 4A). Indeed, it exists in all subsequences of
clones that showed similar expression patterns and does
not exist in subsequences showing no expression. Only in
one exception (clone 134e), expression was not restricted
to tumor tissue, although the fragment contained the tusp
motif (Figure 4B).
Finally, to prove the importance of the tusp motif, point
mutation analysis was carried out. To this end, the DNA
sequence of fragment 212b (Figure 4B) was studied in
Figure 3. Confirmation of tumor-specific expression four exemplary
genes from Class I by qRT-PCR. The expression of the genes mltD,
glpA, pflE and glpT in SL7207 colonizing tumors compared to spleens
was tested.
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Figure 4. Tumor-specific motif and fragmentation of exemplary insert sequences. (A) Logo of the sequence motif found to be overrepresented in
Class I clones. (B) Schematic depiction of four exemplary insert sequences, their respective genomic locus and how they were fragmented. Numbers at
the fragment ends are genome position numbers. Right-hand tables show the percentage of Salmonella expressing GFP_OVA in tumor compared to
spleen tissue for clone number 48, 134, 212, 301 and their respective fragments. Orientation is 50–30 direction of the insert according to its position on
the library plasmid. The black box on the sequences shows the position of the 21 bp motif the sequence of which is shown in (A). Flow cytometric
analysis of tumor and spleen homogenates from mice infected with SL7027 bearing plasmids that contained either the fragment 212a or its mutated
forms (C).
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more detail since it is only about 100 bp long but still
exerts the tumor-specific expression. The tusp motif is
located on the negative strand at positions 399–419
(absolute genomic positions 915 183—915 203, TTTAAT
CTTTATATGAAATAA). To find positions within the
tusp motif that most probably contribute to functionality,
similarity to known regulatory motifs was analyzed using
TOMTOM (17). In general, no hits with a reliable level of
similarity could be identified that cover the entire motif.
However, matches with lower similarity were preferably
located on the edges of the motif. Hence, the following
modification of the original motif was suggested: TGTCA
TCTTTATATGAAATAA (Mut2/4) and TTTAATCTTT
ATATGAAATGC (Mut20/21). (Bold letters indicate
mutated positions).
Newly constructed plasmids bearing the mutated tusp
motif within the fragment 212 b were tested in vivo in
tumor-bearing mice. Results of flow cytometric analysis
of tumor and spleen tissues revealed that single nucleotide
substitutions at positions 2 and 4 of the original motif
(Figure 4A) resulted in an abort of expression in the
tumor while expression in spleen remained negative.
Mutations at positions 20 and 21 had no effect
(Figure 4C). This provides solid evidence for the function-
ality of the identified tusp motif. Further analysis of the
motif against known motif libraries did not reveal signifi-
cant matches. Thus, we speculate that the motif that drives
tumor-specific expression is recognized by a transcription
factor the binding pattern of which is not yet known.
DISCUSSION
For different types of bacteria it could be shown that they
possess the ability to target and colonize tumors and even
induce shrinkage of the cancerous tissue. This fact makes
them an attractive tool for a novel therapeutic approach
namely bacteria-mediated cancer therapy. For instance,
the highly attenuated S. Typhimurium strain VNP20009
has been tested in the clinics with cancer patients.
Although the results were rather disappointing, some of
the patients that had received a high-titered bolus showed
tumor colonization (18,19). In such cases, tumor-specific
expression of therapeutic molecules should have been
beneficial. Importantly, using the same bacterial strain
to treat pet dogs with spontaneous tumors showed an in-
cidence of 43% of tumor colonization and 15% of the dog
patients responded favorably (20). Again, supportive
expression of anticancer molecules might have dramatic-
ally increased the positive effects. This demonstrates the
importance of appropriate expression systems for such
molecules in the tumor-targeting bacteria.
Despite their therapeutic potential, the bacteria used
are still pathogens and have to be rendered absolutely
safe. In the present work, we demonstrate that the expres-
sion of therapeutic molecules by S. Typhimurium can be
restricted to cancerous tissues using tumor-specific pro-
moters. A similar concept using high-throughput chip
technology has been already published by Arrach et al.
(21). We screened a Salmonella promoter-trap library
allowing the discovery of such tumor-specific regulatory
elements without any prerequisite knowledge of the
physiological conditions that induce them. The consecu-
tive steps employed in the screening procedure resulted
in the definition of 12 tumor-specific clones. Our
findings demonstrate that tumor-specific promoters of
S. Typhimurium exist and the strategy employed is
suitable for the identification of such regulatory elements.
From the 184 clones analyzed, 23 clones were classified
into either Class I or II, which were defined to have
strong/medium tumor expression and no/negligible or
weak expression in spleen, respectively. Here, the import-
ance of a quantitative analysis became obvious. Only
when a defined number of bacteria was analyzed, a
reliable characterization of the performance of the
control element could be revealed. The minor fraction of
positive clones in spleen, especially of promoters that fall
into Class I, can be explained by bacteria that had recently
immigrated from the tumor tissue into the spleen.
In addition, the number of GFP positive clones might
be overestimated due to the discrepancy between flow
cytometric measurement and plating results. Thus, such
promoters should be considered truly tumor specific.
Many of the newly defined tumor-specific regulatory
elements apparently respond to the anaerobic environment
in the tumor (Supplementary Table S1). This was expected
as most of the Salmonella reside within the necrotic core or
at its border zone where oxygen supply is scarce (22–24).
On the other hand, we expected that among the
tumor-specific clones several genes would be found that
belong to the same metabolic pathways. However, this
was not the case. The most ‘enriched’ pathways were the
citrate cycle, glycolysis and the reductive carboxylate
cycle, however, each pathway comprised not more than
two clones. A trivial reason for that might be the low
number of S. Typhimurium genes with assigned EC
classes. From the genes associated to clones of Classes I
and II, only 9 out of 23 are categorized in this system.
Thus, the association of such uncharacterized genes with
particular metabolic pathways might have been missed.
Alternatively, some genes of such pathways might be pref-
erentially expressed in cancerous tissue but not completely
silent in healthy organs and thus excluded by our stringent
selection.
Using bioinformatics tools, we searched for a common
denominator within the Class I type of regulatory
elements. We found a motif—now called tusp—which
was present in all of such sequences except one and was
represented in the genome all together only 42 times.
Of such hits, 33 matches were located in potential pro-
moters of genes, 21 of which were annotated
(Supplementary Table S2). Using Gene Ontology (GO)
classification, we found that protein products of five of
such genes were associated with ‘structure-specific DNA
binding’ with P-values of 3.4 105. Thus, we can specu-
late that tusp may have a role as a key regulator, which
triggers a transcriptional cascade of downstream genes.
Investigation of the tusp motifs itself unfortunately gave
no prominent results. No matches to established regula-
tory motifs could be detected using high stringency for
alignment. Thus, we might have discovered a novel bac-
terial DNA element that is involved in the regulation of
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bacterial survival in a microenvironment that is simulated
by the necrotic part of a tumor. By lowering the stringency
of alignment, resemblance with known DNA motifs (e.g.
cpxR, tyrR from E. coli or SygB from Bacillus subtilis)
could be found at both borders of the tusp motif. In ac-
cordance, alteration of two nucleotides at the 30 border of
tusp (Mut2/4) completely silenced reporter expression.
This clearly demonstrates that the tusp motif is important
for the specific function of the regulatory element.
Furthermore, the question arises what the biological
function of the tusp motif is and which environmental
stimuli are linked to it. Different conditions are known
to be present in solid tumors that should be considered.
Hypoxia is a well-known state present in many cancers.
In accordance, reporter gene expression in 8 of the 12
Class I promoters is induced after depletion of oxygen
(Table 3). Low extracellular pH is also often observed in
neopolastic tissues as a result from the high glycolytic flux
(25). This might trigger the promoters not responding to
hypoxia. Alternatively, we could recently show that the
bacteria colonizing tumors are under severe stress most
likely due to defense mechanisms of the host (26). This
induces the formation of biofilms by the bacteria and
could also provide key signals that activate some of the
tumor-specific promoters.
Interestingly, an evaluation of the functions of genes
comprising the tusp motif (Class I clones and matches ac-
cording to genome blast – Supplementary Table S2)
suggests a trend where Salmonella are preparing for rela-
tively slow growth under anaerobic conditions. Further-
more, they appear to react to a deprivation of amino
acids but a high supply of lipids like glycerol and fatty
acids (27).
A similar approach to define tumor-specific promoters
using high-throughput chip technology was reported
recently (21). Screening was carried out in nude mice
bearing the transplantable human prostate carcinoma
PC3. When our list of tumor-specific promoters was
compared with the list of Arrach et al., five fragments
were found in both reports. If we consider such hits as
real, a discrepancy in the discovery accuracy could be
noted. While in our case an accuracy of 47% (5/12) can
be noted, only 5.7% (5/87) can be deduced from Arrach
et al. However, this is most likely due to methodological
differences of the two screening procedures. Our approach
is highly stringent and considers classified elements
only when expression in spleen is completely absent.
In contrast, Arrach et al. used arrays to test for spleen
expression, which probably also includes some low-level
expressers showing that this approach lacks the possibility
for real quantification as it can be provided by FACS or
qRT-PCR analyses. For example, 17 fragments (20% of
hits) reported by Arrach et al. are found to have expres-
sion not restricted to tumor tissue. This might also explain
why the tusp motif is not found in most of the regulatory
elements described by Arrach et al.
Unexpectedly, in our work, a high number of unrespon-
sive clones were present in the final positively sorted
sample. This indicates that the sorting performance was
suboptimal. Negative events should have been excluded.
However, at least the redundancy of such clones was not
as prominent as that for positive clones. Nevertheless, a
second round of screening was carried out with experi-
mental alterations (S. Leschner, unpublished data). First,
the organ preparation included a centrifugation step to
exclude most of the cellular debris and second, sorting
parameters were adjusted using a GFP threshold. The
analysis of 100 randomly selected clones of this altered
sorting revealed that a strong enrichment had occurred.
Almost 50% of these clones could be identified as clone
212 from the first screen. Another 16% exhibited the
sequence of clone 301. The third most prominent clone
(10%) was unknown so far but also found to be unspecif-
ic. The residual clones occurred only once or twice, and
only two of them showed tumor-specific expression. They
could be assigned to the genes spvD and arcA. Therefore,
the initial screening strategy with a lower gating stringency
was more efficient although more laborious.
Cooperative application of lab and bioinformatic tech-
niques proved to be a fruitful and cost-effective approach.
Used complementarily in the present work, tumor-specific
clones were identified and a possible mechanism of their
regulation via a novel DNA motif called tusp is suggested.
In addition, some minor aspects regarding fine regulation
and regulation in the absence of the tusp motif, could be
made. The 100 bp part of clone 134 (fragment 134d) lost
some of the tumor specificity, which was observed for the
original clone 134. This fact suggests that the regulation
of tumor-specific promoters might be more complex.
Additional regulatory elements may be involved, which
in general improve or repress transcriptional initiation.
This also becomes clear when looking at fragment 134e
that contain 32 additional bases spanning the region down
to the TLS of the mltD gene. In this case, the expression is
stronger but less specific compared to the original insert.
We may speculate that other features of DNA, like
melting or specific conformation may play a role, as
well. The presented experimental data show that such
putative elements are not common for all fragments, but
introduce their minor effects in each individual fragment.
The sequences identified in this work allow the
tumor-specific expression of potential therapeutic mol-
ecules by S. Typhimurium. This is a crucial safety aspect
for the use of bacteria as vehicles in anticancer therapy
and needs to be thoroughly investigated. Improving
expressivity of the identified promoter sequences is a
forthcoming activity and unraveling the complete regula-
tory logic underlying the promoters is the first step to this
goal. In addition, this will allow computer generation of
many artificial promoters targeting other types of cancers
in many different model organisms.
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